Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Nyxoah ( (NYXH) ) is now available.
On June 27, 2025, Nyxoah SA announced the issuance of new shares, increasing its share capital to EUR 6,431,121.38 and the total number of voting rights to 37,435,640. This development reflects the company’s strategic efforts to enhance its financial structure and potentially expand its market presence, which could have significant implications for its stakeholders and industry positioning.
The most recent analyst rating on (NYXH) stock is a Buy with a EUR18.00 price target. To see the full list of analyst forecasts on Nyxoah stock, see the NYXH Stock Forecast page.
More about Nyxoah
Nyxoah SA operates in the medical technology industry, focusing on the development and commercialization of innovative solutions for the treatment of sleep apnea. The company is listed on Euronext Brussels and Nasdaq under the ticker NYXH.
Average Trading Volume: 79,723
Current Market Cap: €248.5M
Learn more about NYXH stock on TipRanks’ Stock Analysis page.